Merged with Healthcare Realty Trust Incorporated in July 2022
HTA - Healthcare Trust of America, Inc.
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Scottsdale,
United States
Type: Equity
HTA price evolution
HTA
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $15.42 | $57.07 | $19.46 | $90.34 |
| Short term investments | ||||
| Net receivables | $350.78 | $334.94 | $314.98 | $294.55 |
| Inventory | ||||
| Total current assets | $291.34 | $350.73 | $302.59 | $325.32 |
| Long term investments | $62.45 | $62.83 | $63.21 | $63.59 |
| Property, plant & equipment | $6376.24 | $6397.06 | $6341.55 | $6268.07 |
| Goodwill & intangible assets | $10.01 | $10.72 | $9.38 | $8.85 |
| Total noncurrent assets | ||||
| Total investments | $62.45 | $62.83 | $63.21 | $63.59 |
| Total assets | $6814.91 | $6889.69 | $6775.63 | $6725.4 |
| Current liabilities | ||||
| Accounts payable | $159.66 | $198.08 | $178.02 | $172.65 |
| Deferred revenue | ||||
| Short long term debt | $5.07 | $9.38 | $10.76 | |
| Total current liabilities | $168.16 | $219.86 | $190.46 | $188.99 |
| Long term debt | $3053.88 | $3028.12 | $3079.19 | $3073.47 |
| Total noncurrent liabilities | ||||
| Total debt | $3250.11 | $3224.41 | $3274.3 | $3268.68 |
| Total liabilities | $3518.54 | $3545.37 | $3576.29 | $3565.52 |
| Shareholders' equity | ||||
| Retained earnings | -$1971.9 | -$1915.78 | -$1857.71 | -$1807.75 |
| Other shareholder equity | $1.73 | -$7.04 | -$11.33 | -$12.73 |
| Total shareholder equity | $3212.69 | $3257.6 | $3106.17 | $3101.05 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $57.07 | $118.77 | $37.62 | $133.53 |
| Short term investments | ||||
| Net receivables | $334.94 | $251.73 | $237.02 | $223.41 |
| Inventory | ||||
| Total current assets | $350.73 | $316.91 | $230.32 | $320.17 |
| Long term investments | $62.83 | $64.36 | $65.89 | $67.17 |
| Property, plant & equipment | $6397.06 | $6345.39 | $6285.67 | $5665.62 |
| Goodwill & intangible assets | $10.72 | $10.45 | $12.55 | $98.74 |
| Total noncurrent assets | ||||
| Total investments | $62.83 | $64.36 | $65.89 | $67.17 |
| Total assets | $6889.69 | $6790.69 | $6638.75 | $6188.48 |
| Current liabilities | ||||
| Accounts payable | $198.08 | $200.36 | $171.7 | $185.07 |
| Deferred revenue | ||||
| Short long term debt | $5.07 | $14.96 | $0.03 | |
| Total current liabilities | $219.86 | $215.31 | $171.73 | $185.07 |
| Long term debt | $3028.12 | $3027 | $2749.78 | $2541.23 |
| Total noncurrent liabilities | ||||
| Total debt | $3224.41 | $3225.37 | $2948.43 | $2541.23 |
| Total liabilities | $3545.37 | $3555.77 | $3208.11 | $2847.02 |
| Shareholders' equity | ||||
| Retained earnings | -$1915.78 | -$1727.75 | -$1502.74 | -$1272.31 |
| Other shareholder equity | -$7.04 | -$16.98 | $4.55 | $0.31 |
| Total shareholder equity | $3257.6 | $3174.24 | $3358.01 | $3256.02 |
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $202 | $195.7 | $191.26 | $188.62 |
| Cost of revenue | $65.88 | $60.29 | $59.57 | $57.41 |
| Gross Profit | $136.12 | $135.41 | $131.69 | $131.21 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $12.45 | $17.49 | $10.77 | $10.93 |
| Total operating expenses | $94 | $100.2 | $86.96 | $102.8 |
| Operating income | $42.12 | $35.21 | $44.74 | $28.41 |
| Income from continuing operations | ||||
| EBIT | $42.26 | $39.62 | $45 | $61.14 |
| Income tax expense | ||||
| Interest expense | $23.94 | $23.31 | $23.33 | $23.13 |
| Net income | ||||
| Net income | $18.32 | $16.3 | $21.67 | $38.01 |
| Income (for common shares) | $18.32 | $16.3 | $21.67 | $38.01 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $767.07 | $738.97 | $692.04 | $696.43 |
| Cost of revenue | $236.85 | $226.86 | $211.48 | $220.62 |
| Gross Profit | $530.22 | $512.11 | $480.56 | $475.81 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $49.74 | $42.97 | $41.36 | $35.2 |
| Total operating expenses | $376.89 | $347.76 | $334.25 | $324.72 |
| Operating income | $153.34 | $164.34 | $146.31 | $151.09 |
| Income from continuing operations | ||||
| EBIT | $190.78 | $147.23 | $126.79 | $315.31 |
| Income tax expense | ||||
| Interest expense | $92.76 | $94.61 | $96.63 | $101.85 |
| Net income | ||||
| Net income | $98.02 | $52.62 | $30.15 | $213.46 |
| Income (for common shares) | $98.02 | $52.62 | $30.15 | $213.46 |
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Net income | $18.32 | $16.3 | $21.67 | $38.01 |
| Operating activities | ||||
| Depreciation | $71.01 | $70.97 | $70.27 | $70.39 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.02 | $2.23 | -$0.37 | $2.06 |
| Total cash flows from operations | $49.31 | $114 | $80.69 | $125.57 |
| Investing activities | ||||
| Capital expenditures | -$58.03 | -$140.84 | -$135.75 | -$61.58 |
| Investments | -$1.95 | -$21.69 | -$5.51 | -$45.81 |
| Total cash flows from investing | -$33.18 | -$142.52 | -$138.98 | -$42.05 |
| Financing activities | ||||
| Dividends paid | -$74.38 | -$71.77 | -$70.03 | -$70.02 |
| Sale and purchase of stock | -$1.64 | $197.49 | $53.72 | -$0.13 |
| Net borrowings | $25 | -$50 | $5 | $45 |
| Total cash flows from financing | -$57.77 | $66.13 | -$12.58 | -$26.27 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$41.65 | $37.6 | -$70.87 | $57.25 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | $98.02 | $52.62 | $30.15 | $213.46 |
| Operating activities | ||||
| Depreciation | $283.3 | $283.04 | $280.97 | $271.44 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.26 | $8.92 | $10.13 | $9.76 |
| Total cash flows from operations | $385.62 | $387.96 | $340.39 | $337.4 |
| Investing activities | ||||
| Capital expenditures | -$414.67 | -$337.11 | -$672.91 | -$129.53 |
| Investments | -$72.81 | -$5.09 | $0.74 | $0.7 |
| Total cash flows from investing | -$399.86 | -$319.26 | -$667.29 | $176.31 |
| Financing activities | ||||
| Dividends paid | -$281.82 | -$275.82 | -$256.12 | -$252.65 |
| Sale and purchase of stock | $247.84 | $46.21 | $311.21 | $2.91 |
| Net borrowings | $253.57 | $191.18 | -$242.93 | |
| Total cash flows from financing | -$47.46 | $12.45 | $230.98 | -$498.74 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$61.7 | $81.15 | -$95.91 | $14.97 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 229.08M |
| Revenue | $777.58M |
|---|---|
| EBITDA | $470.65M |
| EBIT | $188.02M |
| Net Income | $94.30M |
| Revenue Q/Q | 5.49% |
| Revenue Y/Y | 4.42% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 14.02 |
| Cash/Share | 0.07 |
| EPS | $0.41 |
|---|---|
| ROA | 1.39% |
| ROE | 2.98% |
| Debt/Equity | 1.09 |
|---|---|
| Net debt/EBITDA | 7.44 |
| Current ratio | 1.73 |
| Quick ratio | 1.73 |